TELADOC HEALTH, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount
TELADOC HEALTH, INC. (TDOC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount of $20.10 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2025-05-01
- TELADOC HEALTH, INC. effective income tax rate reconciliation, nondeductible expense, research and development, amount for the quarter ending 2025-03-31 was $20.10M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 3 month |
|---|---|
| 2025-03-31 | $20.10M 10-Q · filed 2025-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |